• Portfolio
  • Approach
  • News
  • Who We Are
  • Careers
  • Portfolio
  • Approach
  • News
  • Fellowship
  • Who We Are
  • Careers
  • Contact
  • Qiming China
News

Cutting Edge
Lastest News

January 13, 2021
Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning…
Portfolio Company
January 09, 2021
Korro Bio to Present at J.P. Morgan Healthcare Conference
Portfolio Company
January 09, 2021
Talaris Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Portfolio Company
December 18, 2020
Amphivena Therapeutics Announces First Patient Dosed in the Phase 1 Dose Expansion of AMV564
Portfolio Company
December 17, 2020
Cadent Therapeutics Enters Agreement to be Acquired by Novartis
Portfolio Company
December 08, 2020
Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID Undergoing Hematopoietic Cell Transplantation
Portfolio Company
Load More
  • Cambridge

    139 Main Street
    Cambridge, MA 02142

  • Seattle

    2101 4th Avenue,
    Suite 2300
    Seattle, WA 98121

  • SF Bay Area

    8000 Marina Blvd., Suite 110
    Brisbane, CA 94005

  • Approach
  • Contact
  • Fellowship
  • Home
  • News
  • Portfolio
  • Privacy Policy
  • Qiming China
  • Who We Are
  • Careers
  • Who We Are
  • Contact
  • Qiming China

© Copyright 2019 Qiming | Privacy Policy